The effects of surgery, with or without rhGM-CSF, on the angiogenic profile of patients treated for colorectal carcinoma

Cytokine

Volumn 25, Issue 2, 2004, Pages 68-72

  Wu, Francis P K ^a   Westphal, Johan R ^b   Hoekman, Klaas ^a   Mels, Anneke K ^a   Muller, Markwin G Statius ^a   De Waal, Robert W ^b   Beelen, Rob H J ^a   Van Leeuwen, Paul A M ^a   Meijer, Sybren ^a   Cuesta, Miguel A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Angiostatin; Colorectal carcinoma; Endostatin; rhGM CSF; VEGF

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOSTATIN; ENDOSTATIN; INTERLEUKIN 6; PLACEBO; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SODIUM CHLORIDE; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; KRINGLE DOMAIN; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

EID: 0346250111     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2003.09.010     Document Type: Article

References (25)

1. Weitz J., Kienle P., Lacroix J., Willeke F., Benner A., Lehnert T., et al. Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin Cancer Res. 4:1998;343-348.
2. Mels A.K., Muller M.G., Van Leeuwen P.A., Von Blomberg B.M., Scheper R.J., Cuesta M.A., et al. Immune-stimulating effects of low-dose perioperative recombinant granulocyte-macrophage colony-stimulating factor in patients operated on for primary colorectal carcinoma. Br J Surg. 88:2001;539-544.
3. Bussolino F., Ziche M., Wang J.M., Alessi D., Morbidelli L., Cremona O., et al. In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J Clin Invest. 87:1991;986-995.
4. Valdembri D., Serini G., Vacca A., Ribatti D., Bussolino F. In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF. FASEB J. 16:2002;225-227.
5. Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13:1999;9-22.
6. Cohen T., Nahari D., Cerem L.W., Neufeld G., Levi B.Z. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem. 271:1996;736-741.
7. Horiuchi T., Weller P.F. Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am J Respir Cell Mol Biol. 17:1997;70-77.
8. Salven P., Orpana A., Joensuu H. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin Cancer Res. 15:1999;487-491.
9. Dong Z., Yoneda J., Kumar R., Fidler I.J. Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor. J Exp Med. 188:1998;755-763.
10. Moser T.L., Stack M.S., Asplin I., Enghild J.J., Hojrup P., Everitt L., et al. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci U S A. 96:1999;2811-2816.
11. O'Reilly M.S., Holmgren L., Chen C., Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med. 2:1996;689-692.
12. Wen W., Moses M.A., Wiederschain D., Arbiser J.L., Folkman J. The generation of endostatin is mediated by elastase. Cancer Res. 59:1999;6052-6056.
13. Dhanabal M., Ramchandran R., Waterman M.J., Lu H., Knebelmann B., Segal M., et al. Endostatin induces endothelial cell apoptosis. J Biol Chem. 274:1999;11721-11726.
14. Yoon S.S., Eto H., Lin C.M., Nakamura H., Pawlik T.M., Song S.U., et al. Mouse endostatin inhibits the formation of lung and liver metastases. Cancer Res. 59:1999;6251-6256.
15. Butler J., Attiyeh F.F., Daly J.M. Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet. 162:1986;109-113.
16. Hofer S.O., Molema G., Hermens R.A., Wanebo H.J., Reichner J.S., Hoekstra H.J. The effect of surgical wounding on tumour development. Eur J Surg Oncol. 25:1999;231-243.
17. Bondestam J., Salven P., Jaaskela-Saari H., Ikonen T., Lepantalo M., Mattila S., et al. Major surgery increases serum levels of vascular endothelial growth factor only temporarily. Am J Surg. 179:2000;57-59.
18. Bergamini A., Bolacchi F., Bongiovanni B., Cepparulo M., Ventura L., Capozzi M., et al. Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms. Immunology. 101:2000;254-261.
19. Maniwa Y., Okada M., Ishii N., Kiyooka K. Vascular endothelial growth factor increased by pulmonary surgery accelerates the growth of micrometastases in metastatic lung cancer. Chest. 114:1998;1668-1675.
20. Hurwitz H. Oral presentation ASCO; 2003.
21. Muragaki Y., Timmons S., Griffith C.M., Oh S.P., Fadel B., Quertermous T., et al. Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones. Proc Natl Acad Sci U S A. 92:1995;8763-8767.
22. Schuppan D., Cramer T., Bauer M., Strefeld T., Hahn E.G., Herbst H. Hepatocytes as a source of collagen type XVIII endostatin. Lancet. 352:1998;879-880.
23. Felbor U., Dreier L., Bryant R.A., Ploegh H.L., Olsen B.R., Mothes W. Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J. 19:2000;1187-1194.
24. Bjornland K., Buo L., Scott H., Konttinen Y., Johansen H.T., Aasen A.O. Polymorphonuclear elastase in human colorectal carcinoma. Int J Oncol. 12:1998;535-540.
25. Arumugam S., Jang Y.C., Chen-Jensen C., Gibran N.S., Isik F.F. Temporal activity of plasminogen activators and matrix metalloproteinases during cutaneous wound repair. Surgery. 125:1999;587-593.